Clinical Trial Update: Study Evaluating Two Different Sirolimus-based Immunosuppressive Regimens in Elderly Kidney Transplant Recipients [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating two sirolimus-based immunosuppressive regimens in elderly kidney transplant recipients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• End-stage Renal Disease
• Kidney Transplant Rejection

Drugs mentioned

• Sirolimus (Rapamune) (Sirolimus)

Snippet

Sponsor: Wyeth is now a wholly owned subsidiary of Pfizer | Conditions: Kidney Failure, Graft Rejection | Phase 4 | Status: COMPLETED